Cornell University, New York
CD39 is next generation of cardioprotective and cerebroprotective molecules
Published in Medicine and Law Weekly, July 1st, 2005
According to the report from the United States, "Blood platelets maintain vascular integrity and promote primary and secondary hemostasis following interruption of vessel continuity. Biochemical or physical damage to coronary, carotid, or peripheral arteries promotes excessive platelet activation and recruitment culminating in vascular occlusion and tissue ischemia."
A.J. Marcus and colleagues of Cornell University continued, "Currently, inadequate therapeutic approaches to stroke and coronary artery disease (CAD) are a public health...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- A.C.T. Holdings, Inc.
Cloning, cellular reprogramming agreements signed - Affitech AS
Protein L license granted to U.K. biotech company - Angiotech Pharmaceuticals, Inc.
Pharmaceutical firm forms venture initiative - AstraZeneca
Study shows using controller therapy means fewer ER visits by asthmatic children - Bioniche Life Sciences, Inc.
Biopharmaceutical firm granted patent for mycobacterial cell wall technology - China Ntl. Ctr. AIDS STD Ctrl & Prev., Beijing
Findings in HIV/AIDS vaccines provide new insights - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
